@article{houot:hal-02930371,
TITLE = {Total immunotherapy for Hodgkin lymphoma},
AUTHOR = {Houot, Roch and Merryman, Reid W. and Morschhauser, Franck},
URL = {https://hal.science/hal-02930371},
JOURNAL = {Lancet Haematology},
PUBLISHER = {Elsevier},
VOLUME = {7},
NUMBER = {9},
PAGES = {e629-e630},
YEAR = {2020},
MONTH = Sep, DOI = {10.1016/S2352-3026(20)30220-9},
KEYWORDS = {immunotherapy ; brentuximab vedotin ; anti-CTLA4 ; anti-PD1 ; ipilimumab ; nivolumab ; Hodgkin},
PDF = {https://hal.science/hal-02930371/file/Houot_Total%20immunotherapy%20for%20Hodgkin%20lymphoma_accepted.pdf},
HAL_ID = {hal-02930371},
HAL_VERSION = {v1},
}